Napimoga MH et al. |
15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. |
2008 |
J. Pharmacol. Exp. Ther. |
pmid:17928570
|
Stebulis JA et al. |
Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. |
2008 |
Life Sci. |
pmid:18840450
|
Davidson J et al. |
7beta-hydroxy-epiandrosterone modulation of 15-deoxy-delta12,14-prostaglandin J2, prostaglandin D2 and prostaglandin E2 production from human mononuclear cells. |
2008 |
J. Steroid Biochem. Mol. Biol. |
pmid:18996481
|
Reyes-Martin P et al. |
15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. |
2008 |
Pharmacol. Res. |
pmid:18456507
|
Su RY et al. |
15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. |
2008 |
Mol. Cancer Ther. |
pmid:18852146
|
Lee SJ et al. |
15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. |
2008 |
Toxicology |
pmid:18450357
|
Nagata D et al. |
Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. |
2008 |
Cancer Detect. Prev. |
pmid:18789607
|
Kim EH and Surh YJ |
The role of 15-deoxy-delta(12,14)-prostaglandin J(2), an endogenous ligand of peroxisome proliferator-activated receptor gamma, in tumor angiogenesis. |
2008 |
Biochem. Pharmacol. |
pmid:18771658
|
Kim JW et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. |
2008 |
Biochem. Pharmacol. |
pmid:18775681
|
Lee JH et al. |
The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. |
2008 |
J. Immunol. |
pmid:19050284
|
Muñoz U et al. |
On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients. |
2008 |
Cell. Mol. Life Sci. |
pmid:18818877
|
Lutzow YS et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. |
2008 |
J. Dairy Res. |
pmid:18226310
|
Kerr BJ et al. |
The protective effects of 15-deoxy-delta-(12,14)-prostaglandin J2 in spinal cord injury. |
2008 |
Glia |
pmid:18205174
|
Hounoki H et al. |
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. |
2008 |
Bone |
pmid:18242157
|
Kim EH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. |
2008 |
Carcinogenesis |
pmid:18192694
|
Crabb SJ et al. |
BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells. |
2008 |
Oncol. Rep. |
pmid:18288403
|
Hong HY et al. |
Up-regulation of heme oxygenase-1 expression through the Rac1/NADPH oxidase/ROS/p38 signaling cascade mediates the anti-inflammatory effect of 15-deoxy-delta 12,14-prostaglandin J2 in murine macrophages. |
2008 |
FEBS Lett. |
pmid:18291107
|
Liu Y et al. |
Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection. |
2008 |
Vet. Immunol. Immunopathol. |
pmid:18394717
|
Kimura H et al. |
A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. |
2008 |
Nephrol. Dial. Transplant. |
pmid:18367541
|
Kang MA et al. |
Up-regulation of skeletal muscle LIM protein 1 gene by 25-hydroxycholesterol may mediate morphological changes of rat aortic smooth muscle cells. |
2007 |
Life Sci. |
pmid:17161435
|
Sánchez-Gómez FJ et al. |
Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. |
2007 |
Arch. Biochem. Biophys. |
pmid:17169324
|
Tanaka Y et al. |
Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. |
2007 |
Mol. Pharmacol. |
pmid:17151289
|
Suwaki N et al. |
Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. |
2007 |
Placenta |
pmid:16753211
|
Da Silva Morais A et al. |
Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice. |
2007 |
Int. J. Mol. Med. |
pmid:17143554
|
Lee JH et al. |
15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. |
2007 |
J. Korean Med. Sci. |
pmid:17982241
|
Li SJ et al. |
[Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy]. |
2007 |
Zhonghua Fu Chan Ke Za Zhi |
pmid:17983488
|
Reyes-Martin P et al. |
Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. |
2007 |
Pharmacol. Res. |
pmid:17291778
|
Gayarre J et al. |
Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. |
2007 |
Ann. N. Y. Acad. Sci. |
pmid:17405918
|
Li X et al. |
Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. |
2007 |
Nephrol. Dial. Transplant. |
pmid:17255125
|
Yang WZ et al. |
[The effect of ligand of peroxisome proliferators-activated receptor gamma 15d-PGJ2 on the proliferation and activation of hepatic stellate cells]. |
2007 |
Zhonghua Gan Zang Bing Za Zhi |
pmid:17362636
|
Kim HJ et al. |
15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. |
2007 |
Cancer Res. |
pmid:17363578
|
Fionda C et al. |
15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. |
2007 |
J. Immunol. |
pmid:17371958
|
Vunta H et al. |
The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. |
2007 |
J. Biol. Chem. |
pmid:17439952
|
Hwang J et al. |
15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17418102
|
Fulzele SV et al. |
15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. |
2007 |
Anticancer Drugs |
pmid:17159504
|
Arnold R et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. |
2007 |
Immunology |
pmid:17425601
|
Li SJ et al. |
[Effects of peroxisome proliferator-activated receptor gamma and its ligands on cytotrophoblast invasion in first trimester of pregnancy and mechanism thereof]. |
2007 |
Zhonghua Yi Xue Za Zhi |
pmid:17425848
|
Zhao X et al. |
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. |
2007 |
Ann. Neurol. |
pmid:17457822
|
Olmos G et al. |
Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. |
2007 |
Cell. Signal. |
pmid:17658243
|
Paukkeri EL et al. |
PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages. |
2007 |
Br. J. Pharmacol. |
pmid:17891158
|
Ou YC et al. |
Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. |
2007 |
Eur. J. Pharmacol. |
pmid:17341418
|
Chintalgattu V et al. |
PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. |
2007 |
Cardiovasc. Res. |
pmid:17320065
|
Fournier T et al. |
Involvement of PPARgamma in human trophoblast invasion. |
2007 |
Placenta |
pmid:17321592
|
Schlezinger JJ et al. |
An L-tyrosine derivative and PPARgamma agonist, GW7845, activates a multifaceted caspase cascade in bone marrow B cells. |
2007 |
Toxicol. Sci. |
pmid:17400580
|
Rajakariar R et al. |
Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077391
|
Mizutani N et al. |
Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. |
2007 |
J. Immunol. |
pmid:18025192
|
Kim KY et al. |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. |
2007 |
Mol. Pharmacol. |
pmid:17535976
|
Han H et al. |
15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. |
2007 |
Apoptosis |
pmid:17786557
|
Yoon EK et al. |
ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. |
2007 |
J. Korean Med. Sci. |
pmid:18162716
|
Brunoldi EM et al. |
Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. |
2007 |
Chem. Res. Toxicol. |
pmid:17854155
|